The need for antiemetic drugs, which help prevent or relieve nausea and vomiting, is growing for several reasons. A key factor is the rising incidence of conditions and treatments that cause these ...

On Medindia find the complete list of Antiemetics drugs with their available forms and strength. More information is available on each drug including their price list. We recommend consulting your ...

The best medicine for nausea depends on the underlying cause. It may include over-the-counter (OTC) drugs like Dramamine (dimenhydrinate) and Pepto-Bismol (bismuth ...

Also, taking antiemetics (drugs to prevent vomiting and nausea), making sure you're well hydrated, and correcting electrolyte ...

Spanish patients could soon have access to medical cannabis as regulators push forward with a new bill, but its use will be ...

Astellas Pharma today announced that the US Food and Drug Administration (FDA) has approved VYLOY (zolbetuximab-clzb) in ...

001); greater amounts of nausea despite treatment with antiemetics was a predictor of failure to become pain free (p = .002). The most common adverse event was nausea, which was reported in 94 ...

The novel co-occurrence of JAK2, CALR & MPL mutations in a patient with myelofibrosis challenges previous knowledge that ...

If these agents are not effective, clinicians might turn to more-potent antiemetics, such as the dopamine antagonist metoclopramide. To assess the association between metoclopramide use during ...

Acute fatty liver of pregnancy (AFLP) is a rare obstetric complication, and despite improvements in recognition and management over recent decades, it still carries a high risk of maternal and fetal ...

Dr. Ziemke said that current recommendations for nausea treatment include the short-term use of anti-nausea medications, antiemetics, adjusting the dose of the medication or implementing dietary ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved VYLOY™ (zolbetuximab-clzb) in combination ...